Report #2895852

Received May 8, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: Age unknown
State: MI
Recovered: Not recovered
Vaccinated: Apr 20, 2026
Onset: Apr 20, 2026
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	1	—	—

Symptoms (1)

Neuralgia

Symptom narrative

nerve pain in arm; This non-serious case was reported by a consumer via call center representative and described the occurrence of nerve pain in a female patient who received Herpes zoster (Shingrix) for prophylaxis. On 20-APR-2026, the patient received the 1st dose of Shingrix. On 20-APR-2026, 2 hrs after receiving Shingrix, the patient experienced nerve pain (Verbatim: nerve pain in arm). The outcome of the nerve pain was not resolved. It was unknown if the reporter considered the nerve pain to be related to Shingrix. It was unknown if the company considered the nerve pain to be related to Shingrix. Additional Information: GSK Receipt Date: 30-APR-2026 The patient stated that she received her first Shingrix shot 10 days ago and about 2 hours later she began experiencing nerve pain in her arm. She stated she was still experiencing this pain. The batch number was not provided upon follow- up with the reporter.